← Back to Search

Alkylating agents

experimental group for Esophageal Cancer

Phase 3
Waitlist Available
Research Sponsored by Biotech Pharmaceutical Co., Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights

Summary

This clinical study is designed as a phase 3,multicenter, double-blind, randomized, controlled study,to evaluate the efficacy and safety of nimotuzumab combined with paclitaxel+cisplatin（TP) compared with TP as first-line treatment for the metastatic esophageal squamous carcinoma.

Eligible Conditions
  • Esophageal Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Median time of overall survival(OS)
Secondary outcome measures
Median time of progression-free survival（PFS）
Objective response rate（ORR）
Quality of life

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: experimental groupExperimental Treatment3 Interventions
Nimotuzumab+TP(paclitaxel+cisplatin)
Group II: control groupPlacebo Group3 Interventions
Placebo + TP(paclitaxel+cisplatin)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Paclitaxel
FDA approved
Nimotuzumab
Not yet FDA approved
Cisplatin
FDA approved

Find a Location

Who is running the clinical trial?

Biotech Pharmaceutical Co., Ltd.Lead Sponsor
29 Previous Clinical Trials
7,070 Total Patients Enrolled
Lin Shen, DrStudy ChairPeking University Cancer Hospital & Institute
1 Previous Clinical Trials
8 Total Patients Enrolled
~51 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top